Order Article Reprints

Muinelo-Romay L, Vieito M, Abalo A, Nocelo MA, Barón F, Anido U, Brozos E, Vázquez F, Aguín S, Abal M, et al. Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment. Cancers. 2014; 6(1):153-165. https://doi.org/10.3390/cancers6010153

Muinelo-Romay, Laura, Maria Vieito, Alicia Abalo, Marta Alonso Nocelo, Francisco Barón, Urbano Anido, Elena Brozos, Francisca Vázquez, Santiago Aguín, Miguel Abal, and et al. 2014. "Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment" Cancers 6, no. 1: 153-165. https://doi.org/10.3390/cancers6010153

Muinelo-Romay, L., Vieito, M., Abalo, A., Nocelo, M. A., Barón, F., Anido, U., Brozos, E., Vázquez, F., Aguín, S., Abal, M., & López, R. L. (2014). Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment. Cancers, 6(1), 153-165. https://doi.org/10.3390/cancers6010153